ইউরোপীয় ইউনিয়ন - ইংরেজি - EMA (European Medicines Agency)

dechra regulatory b.v. - meloxicam - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation of inflammation and pain in chronic musculoskeletal disorders.dogsalleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

নিউ জিলণ্ড - ইংরেজি - Ministry for Primary Industries

le vet beheer b.v. - meloxicam - meloxicam 1.5 g/litre - anti-inflammatory

নিউ জিলণ্ড - ইংরেজি - Ministry for Primary Industries

le vet beheer b.v. - meloxicam - meloxicam 0.5 g/litre - anti-inflammatory

যুক্তরাজ্য - ইংরেজি - VMD (Veterinary Medicines Directorate)

le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - cats

যুক্তরাজ্য - ইংরেজি - VMD (Veterinary Medicines Directorate)

le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - dogs

যুক্তরাজ্য - ইংরেজি - VMD (Veterinary Medicines Directorate)

dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - cats

যুক্তরাজ্য - ইংরেজি - VMD (Veterinary Medicines Directorate)

dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - dogs

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 1.5 mg in 1 ml - eloxioral oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive eloxioral oral suspension. do not use eloxioral oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

international laboratories, llc - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see  clinical studies (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see  clinical studies (14.1)]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. meloxicam is contraindicated in the following patients: • known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7,5.8) ] • in the setting of coronary artery bypass graft (cabg) surger

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

american health packaging - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 15 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1)]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1)]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2)]. meloxicam is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9)] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic r